Richard L. Verrier
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston
MA 02215
USA
Name/email consistency: high
- T-wave alternans as a therapeutic marker for antiarrhythmic agents. Verrier, R.L., Nieminen, T. J. Cardiovasc. Pharmacol. (2010)
- Basis for sudden cardiac death prediction by T-wave alternans from an integrative physiology perspective. Verrier, R.L., Kumar, K., Nearing, B.D. Heart. Rhythm (2009)
- Heart rate, autonomic markers, and cardiac mortality. Verrier, R.L., Tan, A. Heart. Rhythm (2009)
- Impact of sleep on arrhythmogenesis. Verrier, R.L., Josephson, M.E. Circ. Arrhythm. Electrophysiol (2009)
- Treatment options for patients with coronary artery disease identified as high risk by T-wave alternans testing. Kumar, K., Kwaku, K.F., Verrier, R.L. Curr. Treat. Options. Cardiovasc. Med (2008)
- Noninvasive sudden death risk stratification by ambulatory ECG-based T-wave alternans analysis: evidence and methodological guidelines. Verrier, R.L., Nearing, B.D., Kwaku, K.F. Ann. Noninvasive. Electrocardiol (2005)
- Ambulatory electrocardiogram-based tracking of T wave alternans in postmyocardial infarction patients to assess risk of cardiac arrest or arrhythmic death. Verrier, R.L., Nearing, B.D., La Rovere, M.T., Pinna, G.D., Mittleman, M.A., Bigger, J.T., Schwartz, P.J. J. Cardiovasc. Electrophysiol. (2003)
- Ambulatory ECG monitoring of T-wave alternans for arrhythmia risk assessment. Verrier, R.L., Nearing, B.D. J. Electrocardiol (2003)
- Transatrial access to the normal pericardial space: a novel approach for diagnostic sampling, pericardiocentesis, and therapeutic interventions. Verrier, R.L., Waxman, S., Lovett, E.G., Moreno, R. Circulation (1998)